Exact Mass: 663.3618

Exact Mass Matches: 663.3618

Found 28 metabolites which its exact mass value is equals to given mass value 663.3618, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

C31H49N7O9

C31H49N7O9 (663.3592)


   

Arg Val Phe Asp Lys

Arg Val Phe Asp Lys

C30H49N9O8 (663.3704)


   

Goniomedinone

Goniomedinone

[C40H47N4O5]+ (663.3546)


   

Phe Arg Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)


   

Phe Arg Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Phe Trp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Arg Phe Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)


   

Arg Phe Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Arg Arg Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)


   

Arg Arg Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)


   

Arg Trp Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Arg Trp Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)


   

Trp Phe Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Trp Arg Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Trp Arg Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)


   

RVFDK

Arg-Val-Phe-Asp-Lys

C30H49N9O8 (663.3704)


   

BQ-788 (sodium salt)

BQ-788 (sodium salt)

C34H50N5NaO7 (663.3608)


   

methyl (1R,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-2-oxo-21-oxa-17,24,29-triaza-9-azoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-3,5(18),19,30,32,34-hexaene-28-carboxylate

methyl (1R,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-2-oxo-21-oxa-17,24,29-triaza-9-azoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-3,5(18),19,30,32,34-hexaene-28-carboxylate

C40H47N4O5+ (663.3546)


   

(9Z)-17-hydroxyoctadec-9-enoate 17-O-(6-O-acetyl-beta-D-glucosyl)-(1->2)-beta-D-glucoside

(9Z)-17-hydroxyoctadec-9-enoate 17-O-(6-O-acetyl-beta-D-glucosyl)-(1->2)-beta-D-glucoside

C32H55O14- (663.3592)


   

(1S,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-28-methoxycarbonyl-21-oxa-17,29-diaza-9,24-diazoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-2,4,17,19,30,32,34-heptaen-2-olate

(1S,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-28-methoxycarbonyl-21-oxa-17,29-diaza-9,24-diazoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-2,4,17,19,30,32,34-heptaen-2-olate

C40H47N4O5+ (663.3546)


   

PC 20:5/7:3;O

PC 20:5/7:3;O

C35H54NO9P (663.3536)


   

PC 27:8;O

PC 27:8;O

C35H54NO9P (663.3536)


   

LNAPE 30:8;O

LNAPE 30:8;O

C35H54NO9P (663.3536)


   

PE 22:5/8:3;O

PE 22:5/8:3;O

C35H54NO9P (663.3536)


   

PE 30:8;O

PE 30:8;O

C35H54NO9P (663.3536)


   

ST 27:4;O6;HexNAc

ST 27:4;O6;HexNAc

C35H53NO11 (663.3618)


   

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

C31H49N7O9 (663.3592)


   

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-7-[2-(methylsulfanyl)ethyl]-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-7-[2-(methylsulfanyl)ethyl]-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

C32H57NO11S (663.3652)